Increased DNA methylation of the SLC30A8 gene promoter is associated with type 2 diabetes in a Malay population

[1]  C. Östenson,et al.  DNA Methylation Analysis of the Insulin-like Growth Factor-1 (IGF1) Gene in Swedish Men with Normal Glucose Tolerance and Type 2 Diabetes , 2014 .

[2]  C. Ling,et al.  Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets , 2014, BMC Medicine.

[3]  C. Gieger,et al.  DNA methylation and body-mass index: a genome-wide analysis , 2014, The Lancet.

[4]  H. Falhammar,et al.  Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy , 2014, Clinical Epigenetics.

[5]  Thomas Meitinger,et al.  Loss-of-function mutations in SLC30A8 protect against type 2 diabetes , 2014, Nature Genetics.

[6]  C. Östenson,et al.  Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men , 2013, Clinical Epigenetics.

[7]  C. Östenson,et al.  Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes , 2013, Clinical Epigenetics.

[8]  J. Zierath,et al.  Epigenetic flexibility in metabolic regulation: disease cause and prevention? , 2013, Trends in cell biology.

[9]  Huidong Shi,et al.  A genome-wide methylation study on obesity , 2013, Epigenetics.

[10]  C. Ling,et al.  Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets , 2013, Diabetologia.

[11]  M. McCarthy,et al.  The Genetic and Epigenetic Basis of Type 2 Diabetes and Obesity , 2012, Clinical pharmacology and therapeutics.

[12]  H. Gu,et al.  Genetic association studies in diabetic nephropathy. , 2012, Current diabetes reviews.

[13]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[14]  B. Pulendran,et al.  4th Aegean Conference on The Crossroads between Innate and Adaptive Immunity , 2011, Nature Immunology.

[15]  W. Reik,et al.  Uncovering the role of 5-hydroxymethylcytosine in the epigenome , 2011, Nature Reviews Genetics.

[16]  Toshiko Tanaka,et al.  Total Zinc Intake May Modify the Glucose-Raising Effect of a Zinc Transporter (SLC30A8) Variant , 2011, Diabetes.

[17]  L. Groop,et al.  Genetics of type 2 diabetes. , 2011, Clinical chemistry.

[18]  J. Florez,et al.  The genetics of type 2 diabetes: what have we learned from GWAS? , 2010, Annals of the New York Academy of Sciences.

[19]  M. Isa,et al.  Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. , 2010, The Medical journal of Malaysia.

[20]  M. McCarthy,et al.  Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. , 2010, Molecular genetics and metabolism.

[21]  L. Groop,et al.  Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes , 2009, Diabetes.

[22]  R. Kawamori,et al.  Downregulation of ZnT8 expression in pancreatic β-cells of diabetic mice , 2009, Islets.

[23]  C. Meshul,et al.  Down-Regulation of ZnT8 Expression in INS-1 Rat Pancreatic Beta Cells Reduces Insulin Content and Glucose-Inducible Insulin Secretion , 2009, PloS one.

[24]  T. Lim,et al.  A report of the Malaysian dialysis registry of the National Renal Registry, Malaysia. , 2008, The Medical journal of Malaysia.

[25]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[26]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[27]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[28]  S. Azhar,et al.  Dialysis for end stage renal disease: a descriptive study in Penang Hospital. , 2005, The Medical journal of Malaysia.

[29]  Z. Morad,et al.  Prevention of renal failure: The Malaysian experience , 2005, Kidney International.

[30]  A. Favier,et al.  Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. , 2004, Diabetes.

[31]  K A Baggerly,et al.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.

[32]  I. Gut,et al.  Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. , 2003, BioTechniques.

[33]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[34]  S. Maeda,et al.  Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. , 2011, Endocrine journal.

[35]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[36]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.